A. Mayweg

Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction

Zhisen Zhang, Zhaohu Lin, Zheng Zhou et al. · ACS Medicinal Chemistry Letters · 2014 · 166 citations · Full text

Yap Interface 3, Peptide Engineering, Molecular Biology +21

β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease

Hans Hilpert, Wolfgang Guba, Thomas J. Woltering et al. · Journal of Medicinal Chemistry · 2013 · 136 citations · Full text

Neurochemical Biomarkers, Pharmacotherapy, Alzheimer ’ +24

Late-Stage Intermolecular CH Activation for Lead Diversification:  A Highly Chemoselective Oxyfunctionalization of the C-9 Position of Potent Bryostatin Analogues

Paul A. Wender, Michael K. Hilinski, A. Mayweg · Organic Letters · 2004 · 95 citations

C-9 Position, Organic Chemistry, Chemistry +16

Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors

Zongxing Qiu, Xianfeng Lin, Mingwei Zhou et al. · Journal of Medicinal Chemistry · 2016 · 72 citations · Full text

Capsid Protein, Antiviral Drug, Hepatitis B Virus +17

Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action

Xingchun Han, Chengang Zhou, Min Jiang et al. · Journal of Medicinal Chemistry · 2018 · 70 citations · Full text

Antiviral Drug, Pharmaceutical Chemistry, Dhq Chemical Series +18